Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

Allergan

Status and phase: Completed; Phase 3

Conditions: Eyelashes

Treatments: Drug: Bimatoprost 0.03% sterile solution; Drug: vehicle sterile solution

Study type: Interventional

Funder types: Industry

Identifiers

NCT00693420

192024-032

Details and patient eligibility

About

This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.

Enrollment: 278 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Dissatisfaction with eyelash prominence,
• Eyelash prominence assessment of minimal or moderate,
• Ability to provide written informed consent

Exclusion criteria

• Subjects without visible lashes,
• Asymmetrical (uneven lashes or longer on one side than the other) eyelashes,
• Any eye disease or abnormality,
• Eye surgery,
• Permanent eyeliner,
• Eyelash implants,
• Eyelash extension application,
• Any use of eyelash growth products within 6 months of study entry,
• Treatments that may effect hair growth,
• Subjects requiring eye drop medications for glaucoma,
• Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

278 participants in 2 patient groups, including a placebo group

1

Experimental group

Description:

Bimatoprost 0.03% solution

Treatment:

Drug: Bimatoprost 0.03% sterile solution

2

Placebo Comparator group

Description:

Vehicle solution

Treatment:

Drug: vehicle sterile solution